GNS.LSE Genus PLC

Healthcare Biotechnology London Exchange
23.84 GBX
Close of Nov 3, 2026
1,943 3,220
Market cap
GBX 1.54B
P/E
5.6x
P/B
2.05x
ROE
37.2%
Dividend yield
1.36%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is GNS.LSE undervalued?

Graham number
Price23.84
Graham value33.38
Discount28.6%

GNS.LSE trades 28.6% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Genus PLC fundamental analysis

No fundamental analysis for Genus PLC yet.

Genus PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Genus PLC

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and…

Full company profile